No Data
No Data
Lianhe Chemical Technology (002250.SZ): The impact of USA tariff policy on the company is limited, as the business involving exports to USA ports accounts for a small proportion.
On April 8, Gelonghui reported that Lianhe Chemical Technology (002250.SZ) stated on the investor interaction platform that the tariff policy in the USA has limited impact on the company, as the business related to exports to USA ports accounts for a small proportion, and most of these products already have short-term tariff solutions. Tariff policy changes quickly, and we are in immediate communication with customers about the stability of the subsequent supply chain for the affected products, tax-saving rationalization, and other issues. The company will actively discuss long-term flexible supply chain solutions with customers based on overseas bases to cope with the increasingly complex international trade situation.
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Lianhe Chemical Technology (002250.SZ): First repurchase of 1.127 million shares involving an amount of 7.85519 million yuan.
Glorious Union reported on March 12 that Lianhe Chemical Technology (002250.SZ) announced that on March 12, 2025, it will first repurchase shares through a dedicated Share Buyback securities account via centralized bidding Trade, with a total of 1.127 million shares repurchased, accounting for 0.1237% of the company's current total equity, with a highest Fill Price of 6.97 yuan/share, a lowest Fill Price of 6.97 yuan/share, and a total amount of 7.85519 million yuan (excluding transaction fees).
Lianhe Chemical Technology (002250.SZ): Currently, the pharmaceutical clients the company collaborates with are all excellent large companies within the world pharmaceutical Industry.
On March 12, Gelonghui reported that Lianhe Chemical Technology (002250.SZ) recently stated during investor relations activities that the company's pharmaceutical Business is advancing as planned and is expected to maintain stable growth. The company implements a "Major Client Strategy," and currently, all pharmaceutical clients it collaborates with are large outstanding companies in the global pharmaceutical Industry. Building on the existing partnerships with major clients, the company continues to strive to expand new clients, enhance research and development capabilities, and strengthen technical reserves. Regarding capacity construction, the company is undertaking investment construction work according to actual conditions and plans to build new pharmaceutical workshops to meet the future development needs of the pharmaceutical Business.
Express News | This week, 13 listed companies announced the disclosure of share repurchase and shareholding related to re-loans. Shareholders of Gree Electric Appliances, Inc. of Zhuhai plan to increase their shareholding with loans not exceeding 1.47 billion yuan.